Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review.
Chinonyerem Ogadi IheanachoValentine U OdiliUchenna I H EzePublished in: Future journal of pharmaceutical sciences (2021)
The online version contains supplementary material available at 10.1186/s43094-021-00224-4.